AHNS01
RISK LEVEL STRATIFICATION USING CIRCULATING TUMOR DNA IN HEAD AND NECK CANCER PATIENTS
Cancer Biology
Liyona Kampel, MD, PhD; Sara Davidova, MD; Shlomo Zuriel, PhD; Narin Carmel Neiderman, MD; Dov Hershkovitz, MD, PhD; Nidal Muhanna, MD, PhD
Tel Aviv Sourasky Medical Center
AHNS02
EVEROLIMUS INHIBITS P53 MUTANT HNSCC BY MODULATING ANGIOGENESIS AND LYMPHANGIOGENESIS MECHANISMS LINKED TO MTOR/HIF1A/VEGF SIGNALING
Janmaris Marin Fermin; Md Maksudul Alam, PhD; Kyle A Boudreaux, MS, IV; Landon D Goodreau; Taylor L Powell; Tara Moore-Medlin; Xiaohua Rong; Jerry McLarty; Xin Gu; Cherie-Ann O Nathan
LSU-Health Shreveport
AHNS03
RADIATION IMPROVES THE THERAPEUTIC ANTIBODY DELIVERY IN HEAD AND NECK CANCERS.
Laura Freeman, MD; Guolan Lu, PhD; Eben Rosenthal
Stanford
AHNS04
CHARACTERIZING THE TUMOR MICROENVIRONMENT OF IMMUNOSUPPRESSED CUTANEOUS SQUAMOUS CELL CARCINOMA
Mica Glaun, MD1; Frederico Gleber-Netto, PhD1; Priyadharsini Nagarajan, MD1; Tongxin Xie1; Jennifer Covello1; Shamima Akhter1; Adebayo Adewale1; Erez Baruch1; Michael Wong1; Kenneth Tsai2; Elsa Flores2; Michael Migden1; Deborah Silverman1; Ryan Goepfert1; Yejing Ge1; Padamanee Sharma1; James Allison1; Jeffrey Myers1; Neil Gross1; Moran Amit1
1MD Anderson Cancer Center; 2Moffitt Cancer Center
AHNS06
MASS SPECTROMETRY IMAGING OF THE METABOLIC LANDSCAPE OF HUMAN PAPILLOMAVIRUS-ASSOCIATED VERSUS CARCINOGEN-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA
Richard A Harbison, MD1; William Andrews2; Rajeev Pandey1; Rebecca Dempsey1; Rajarsi Mandal1; Robert Casero1; Drew Pardoll1; Carole Fakhry1; Maureen Kane2; Jonathan Powell1; Erika Pearce1
1Johns Hopkins Hospital; 2University of Maryland
AHNS Annual Meeting
Held during the Combined Otolaryngology
Spring Meetings (COSM)
April 27-28, 2022
Hyatt Regency Dallas
Dallas, TX